Synageva BioPharma (GEVA) Announces $80M Common Offering

Synageva BioPharma Corp. (“Synageva”) (NASDAQ: GEVA), has commenced a $80 million underwritten public offering of shares of its common stock. In connection with this offering, Synageva expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. Morgan Stanley and J.P. Morgan are acting as joint book-running managers in the offering, and Cowen and Company is acting as co-manager in the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Attovia Therapeutics prices IPO at $17 per share on Nasdaq
• PreveCeutical closes fourth tranche, raising $1M in total placement
• Ameren Corp (AEE) files mixed shelf